Remove resource products survey
article thumbnail

Survey reports on falsification of medical devices

European Pharmaceutical Review

A new report by the Committee of Experts on minimising the public health risks posed by falsified medical products and related crimes (CD-P-PH/CMED) shares insight on how authorities perceive and address the falsification of medical devices. Survey findings Survey responses confirmed the existence of falsified medical devices.

91
article thumbnail

End-Of-Life Management for Single-Use Products in Bioproduction Part 2

ISPE

The focus of the survey was on current sustainability goals that end user organizations have committed to and the practices of disposal for those single-use assemblies. The good news for our industry is that most of the respondents in this survey were supportive in becoming more actively engaged in effective end-of-life management solutions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

European approval of SC atezolizumab offers quicker and more flexible cancer treatment

Hospital Pharmacy Europe

In August 2023, the NHS in England became the first health system in the world to roll out SC atezolizumab after its approval by the Medicines and Healthcare products Regulatory Agency (MHRA).

Hospitals 101
article thumbnail

Consumers want convenient, online doctor-finding tools

pharmaphorum

New survey data from Press Ganey suggests that pharma may be able to get an edge by integrating physician directories into brand websites. And a new survey of 1,126 Americans shows that at least in the states this strategy has a lot of legs. “I But one of the findings from the survey is from specifically that demographic, 41.3%

article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

By screening through huge amounts of data, as well as crunching those not suitable for the totally automated mode along with them at a time, AI provides stakeholders actionable information that they can use in strategic planning and resource allocation. cited 2023Dec]. Available from: [link] Rajkomar A, Dean J, Kohane I. N Engl J Med.

FDA 122
article thumbnail

Innovation boosts R&D outlook despite COVID difficulties – report

pharmaphorum

Ayming surveyed a combination of 330 business executives and R&D managers from 13 countries across North America and Europe. The report says it is clear that technology plays a growing role in developing new products and services, while ‘Industry 4.0’ Yet these emerging trends seem chiefly driven by private resources.

114
114
article thumbnail

Asia-Pacific Regulatory & Industry Views on Drug Shortage Prevention

ISPE

A preview was given of the new ISPE Drug Shortages Prevention Model in which drug shortage prevention focus areas such as quality and manufacturing, regulatory and technology, and innovation align with ISPE’s Communities of Practice and other resources.